Added to YB: 2026-08-06
Pitch date: 2026-08-04
BAYN.DE [neutral]
Bayer Aktiengesellschaft
-0.57%
current return
Author Info
Lux Opes Research covers European companies. Lots of them. Sign up for the newsletter.
Company Info
Bayer Aktiengesellschaft operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil.
Market Cap
EUR 47.4B
Pitch Price
EUR 49.50
Price Target
N/A
Dividend
0.23%
EV/EBITDA
7.76
P/E
-27.27
EV/Sales
1.78
Sector
Pharmaceuticals
Category
turnaround
Bayer (BAYN Germany): Crop Science recovery and resilient Pharma drive a stronger quarter
BAYN.DE (earnings): Q2 sales +1.2% to €10.87bn, adj EBITDA +1.9% to €2.14bn, adj EPS €0.95, beating expectations. Crop Science EBITDA jumped to €902m (18.4% margin vs 14.5%). Pharma resilient as Nubeqa +61%, Kerendia +80% offset Xarelto -42%. Net debt guide cut to €29-30bn post Apollo deal.
Read full article (2 min)